Wall Street Journal has a report on Medco Health Solutions' new partnership with the US Food and Drug Administration "to study the role of patients' genetic makeup in prescribing medications, a collaboration aimed at expanding the scientific evidence for 'personalized medicine,'" the article says. "The two-year agreement calls for Medco to deliver reports to the FDA about pharmacogenomic testing, including physician participation in such testing and the usefulness of testing in prescribing medicines."
Personalized Medicine Climbs the Ranks
Aug 19, 2008
What's Popular?